Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Sombra Cosmetics, Inc
WARNING LETTER
•Sombra Cosmetics, Inc•July 26, 2024

Sombra Cosmetics, Inc – FDA Warning Letter, Jul 26, 2024

Record Details

The FDA inspected Sombra Cosmetics, Inc. from July 15-26, 2024, identifying significant CGMP violations for finished pharmaceuticals, rendering their drug products adulterated. The firm's August 16, 2024, response was deemed inadequate due to insufficient documentation and evidence of corrective actions.

Key violations include: 1. **Inadequate Production and Process Controls (21 CFR 211.100(a)):** * **Water System Deficiencies:** Failure to adequately demonstrate water suitability for manufacturing and cleaning, including inadequate TOC and conductivity testing, and microbial samples showing "TNTC" Gram-negative rods without further identification. The remediation plan lacked detail and timelines. * **Inadequate Process Validation:** Insufficient data to validate manufacturing processes and qualify equipment. The provided sample validation lacked acceptance criteria and product specifications, and no timeline for validation was given. * **Required Actions:** Comprehensive independent remediation plan for water systems (validation reports, improvements, monitoring procedures, action/alert limits), detailed risk assessment for distributed products due to water issues, and a detailed summary of the validation program for product lifecycle, including PPQ timelines, protocols, and cleaning validation improvements.

2. **Failure to Test Components (21 CFR 211.84(d)(1) and 211.84(d)(2)):** * Failure to

Company
Sombra Cosmetics, Inc
Inspection date
July 26, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Francis Godwin (Director)
View Company Profile

ID · 994779d5-22b8-4d09-9c7a-3069a96a61ec

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 21121 CFR 211.100(a)21 CFR 211.84(d)(1)21 CFR 211.84(d)(2)21 CFR 211.160(b)21 CFR 211.22(a)21 CFR 211.19221 CFR 211.166(a)

Full citation text and observation details available on the Dashboard.

Other documents for Sombra Cosmetics, Inc
  • 483 - 2024-07-26July 26, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Sombra Cosmetics, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.